Monday, August 15, 2016

BeyondSpring Announces First Patient Enrolled in China in a Global Phase 3 Trial of Plinabulin for Non-Small Cell Lung Cancer

… 3 trials in non-small cell lung cancer (NSCLC) and has participated in … and 3rd line non-small cell lung cancer (NSCLC) in combination with docetaxel … cell lung cancer (NSCLC), which accounts for approximately 85 percent of all lung cancer … anticancer agent in non-small cell lung cancer. The Company is also planning …

No comments:

Post a Comment